An interesting ME/CFS/COVID crossover study used DNA methylation in ME/CFS patients and observed a downregulation of the expression of the human angiotensin-converting enzyme 2 (ACE2) used by the SARS-CoV-2 virus during infection, but not homologous ACE. This evidence concerns the gene ACE and myalgic encephalomeyelitis/chronic fatigue syndrome.